HLB Therapeutics Co.,Ltd. (115450.KQ)

KRW 8030.0

(6.36%)

Total Debt Summary of HLB Therapeutics Co.,Ltd.

HLB Therapeutics Co.,Ltd.'s latest annual total debt in 2023 was 10.02 Billion KRW , down -80.77% from previous year.
HLB Therapeutics Co.,Ltd.'s latest quarterly total debt in 2024 Q2 was 24.75 Billion KRW , up 144.07% from previous quarter.
HLB Therapeutics Co.,Ltd. reported annual total debt of 52.13 Billion KRW in 2022, up 1.96% from previous year.
HLB Therapeutics Co.,Ltd. reported annual total debt of 51.12 Billion KRW in 2021, up 283.42% from previous year.
HLB Therapeutics Co.,Ltd. reported quarterly total debt of 10.14 Billion KRW for 2024 Q1, up 1.2% from previous quarter.
HLB Therapeutics Co.,Ltd. reported quarterly total debt of 36.08 Billion KRW for 2023 Q1, down -30.78% from previous quarter.

Annual Total Debt Chart of HLB Therapeutics Co.,Ltd. (2023 - 2016)

Historical Annual Total Debt of HLB Therapeutics Co.,Ltd. (2023 - 2016)

Year	Total Debt	Total Debt Growth
2023	10.02 Billion KRW	-80.77%
2022	52.13 Billion KRW	1.96%
2021	51.12 Billion KRW	283.42%
2020	13.33 Billion KRW	-72.66%
2019	48.76 Billion KRW	450.87%
2018	8.85 Billion KRW	-37.32%
2017	14.12 Billion KRW	37.09%
2016	10.3 Billion KRW	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	24.75 Billion KRW	144.07%
2024 Q1	10.14 Billion KRW	1.2%
2023 Q1	36.08 Billion KRW	-30.78%
2023 Q4	10.02 Billion KRW	-46.56%
2023 Q3	18.75 Billion KRW	-23.41%
2023 Q2	24.48 Billion KRW	-32.15%
2023 FY	10.02 Billion KRW	-80.77%
2022 Q3	57.79 Billion KRW	0.76%
2022 Q4	52.13 Billion KRW	-9.8%
2022 Q1	52.41 Billion KRW	2.52%
2022 Q2	57.35 Billion KRW	9.43%
2021 Q3	1.71 Billion KRW	0.0%
2021 Q4	51.12 Billion KRW	2888.24%

Peer Total Debt Comparison of HLB Therapeutics Co.,Ltd.

Name	Total Debt	Total Debt Difference
HLB Co., Ltd.	62.7 Billion KRW	84.017%
iNtRON Biotechnology, Inc.	402.9 Million KRW	-2387.494%
BINEX Co., Ltd.	53.5 Billion KRW	81.269%
Bioneer Corporation	44.63 Billion KRW	77.548%
Anterogen.Co.,Ltd.	9.74 Billion KRW	-2.895%
MEDIPOST Co., Ltd.	52.33 Billion KRW	80.851%
CrystalGenomics, Inc.	32 Billion USD	68.683%
Helixmith Co., Ltd	20.22 Billion KRW	50.452%
Chabiotech Co.,Ltd.	449.63 Billion KRW	97.771%
Medy-Tox Inc.	82.83 Billion KRW	87.9%
Peptron, Inc.	9.13 Billion KRW	-9.738%
Amicogen, Inc.	149.59 Billion KRW	93.3%
Genexine, Inc.	67.42 Billion KRW	85.136%
LegoChem Biosciences, Inc.	12.64 Billion KRW	20.734%
ALTEOGEN Inc.	83.76 Billion KRW	88.036%
PharmaResearch Co., Ltd.	34.3 Billion KRW	70.786%
SillaJen, Inc.	9.69 Billion KRW	-3.359%
JETEMA, Co., Ltd.	130.49 Billion KRW	92.32%
OliX Pharmaceuticals,Inc	39.35 Billion KRW	74.535%
Genomictree Inc.	1.83 Billion KRW	-446.279%
MedPacto, Inc.	8.6 Billion KRW	-16.483%
D&D Pharmatech	8.13 Billion KRW	-23.211%
EASY BIO,Inc.	82.27 Billion KRW	87.819%
GI Innovation, Inc.	3.72 Billion KRW	-169.358%